Table 1 Clinical characteristics of reports with Pexidartinib from the FAERS database.
Characteristic | Case Number, n | Proportion, % |
|---|---|---|
Total | 844 | |
Gender | ||
Female | 461 | 54.60% |
Male | 283 | 33.50% |
Missing | 100 | 11.80% |
Weight | ||
<50 kg | 1 | 0.10% |
>100 kg | 12 | 1.40% |
50–100 kg | 79 | 9.40% |
Missing | 752 | 89.10% |
Age | ||
<18 | 13 | 1.50% |
18–64.9 | 222 | 26.30% |
65–85 | 28 | 3.30% |
Missing | 581 | 68.80% |
Reporter’s type | ||
Consumer | 424 | 50.20% |
Physician | 212 | 25.10% |
Pharmacist | 17 | 2.00% |
Other health-professional | 191 | 22.60% |
Outcomes | ||
Hospitalization—initial or prolonged | 62 | 7.30% |
Disability | 3 | 0.40% |
Life-threatening | 1 | 0.10% |
Death | 14 | 1.70% |
Other serious | 99 | 11.70% |
Non-Serious | 665 | 78.80% |
Reported countries (top five) | ||
America | 843 | 99.90% |
Italy | 1 | 0.10% |
